These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 9108922

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of urine protein content in dogs with pituitary-dependent hyperadrenocorticism.
    Hurley KJ, Vaden SL.
    J Am Vet Med Assoc; 1998 Feb 01; 212(3):369-73. PubMed ID: 9470045
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of mitotane treatment for adrenal tumor versus pituitary-dependent hyperadrenocorticism in dogs.
    Feldman EC, Nelson RW, Feldman MS, Farver TB.
    J Am Vet Med Assoc; 1992 Jun 01; 200(11):1642-7. PubMed ID: 1320600
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Systemic arterial blood pressure and urine protein/creatinine ratio in dogs with hyperadrenocorticism.
    Ortega TM, Feldman EC, Nelson RW, Willits N, Cowgill LD.
    J Am Vet Med Assoc; 1996 Nov 15; 209(10):1724-9. PubMed ID: 8921029
    [Abstract] [Full Text] [Related]

  • 10. ACTH-independent hyperadrenocorticism due to food-dependent hypercortisolemia in a dog: a case report.
    Galac S, Kars VJ, Voorhout G, Mol JA, Kooistra HS.
    Vet J; 2008 Jul 15; 177(1):141-3. PubMed ID: 17572120
    [Abstract] [Full Text] [Related]

  • 11. Effect of o,p'DDD therapy on endogenous ACTH concentrations in dogs with hypophysis-dependent hyperadrenocorticism.
    Nelson RW, Feldman EC, Shinsako J.
    Am J Vet Res; 1985 Jul 15; 46(7):1534-7. PubMed ID: 2992329
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mitotane treatment of 32 dogs with cortisol-secreting adrenocortical neoplasms.
    Kintzer PP, Peterson ME.
    J Am Vet Med Assoc; 1994 Jul 01; 205(1):54-61. PubMed ID: 7928549
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of the use of baseline cortisol concentration as a monitoring tool for dogs receiving trilostane as a treatment for hyperadrenocorticism.
    Cook AK, Bond KG.
    J Am Vet Med Assoc; 2010 Oct 01; 237(7):801-5. PubMed ID: 20919845
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Plasma cortisol response to ketoconazole administration in dogs with hyperadrenocorticism.
    Feldman EC, Bruyette DS, Nelson RW, Farver TB.
    J Am Vet Med Assoc; 1990 Jul 01; 197(1):71-8. PubMed ID: 2370223
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Diagnosis of hyperadrenocorticism in dogs as compared to human diagnostic methods: a review.
    Thuróczy J, Balogh L, Huszenicza G, Jánoki GA, Kulcsár M.
    Acta Vet Hung; 1998 Jul 01; 46(2):157-73. PubMed ID: 9704520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.